Ischemic stroke in the setting of chronic immune thrombocytopenia in an elderly patient-a therapeutic dilemma

10Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Chronic immune thrombocytopenia (ITP) carries a poor prognosis in the elderly patients. Increasing evidence proposes that a subgroup of patients with chronic ITP may be more susceptible to ischemic stroke. An 84-year-old Caucasian man with multiple ischemic stroke risk factors presented with acute onset of slurred speech, confusion, and unsteady gait. Physical examination and neurologic imaging were consistent with a new left thalamic infarct. Platelet counts ranged between 40 000 × 109/L and 65 000 × 109 /L. Antiplatelet therapy for his newly acquired stroke was not initiated considering his low platelet counts and for mildly symptomatic thrombocytopenia, and the patient was discharged home. Both hematologic and neurologic guidelines for the management of chronic ITP and stroke have contradictory goals. Although anticoagulation is mandated in acute stroke, ITP causes low platelet counts that increase bleeding complications. © 2012 The Author(s).

Author supplied keywords

Cite

CITATION STYLE

APA

Peña, A. D. L., Fareed, J., Thethi, I., Morales-Vidal, S., Schneck, M. J., & Shafer, D. (2012). Ischemic stroke in the setting of chronic immune thrombocytopenia in an elderly patient-a therapeutic dilemma. Clinical and Applied Thrombosis/Hemostasis, 18(3), 324–326. https://doi.org/10.1177/1076029611425380

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free